IRCT2016022826802N1已完成2 期
Assessment the efficacy of atomoxetin(stramox) in autism spectrum disorders 6-17 years old
Vice chancellor for research of mashhad university of medical sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 years 至 17 years（—）
- 性别
- All
入选标准
- •The inclusion criteria: Of all patients with ASD, ranging in age from 6 to 17 years; Parent's Consent; No obvious organic disease; The lack of other psychiatric disorders; Not taking other psychoactive medications other than risperidone; IQ higher than 50 on the basis of Weiland test
- •The exclusion criteria: In the absence of cooperation of parents after inclusion; the risk of any side effect or another disease that cause a problem in results.
排除标准
- 未提供
研究者
相似试验
招募中
2 期
The effectiveness of atomoxetine with Ritalin and fluoxetine on anxiety, the severity of attention deficit hyperactivity disorder, and the performance of children with ADHD - Attention Deficit Hyperactivity DisorderIRCT20211004052670N2Esfahan University of Medical Sciences100
已完成
3 期
Study of therapeutic effects of Atomoxtein in reducing the symptoms of patients with recurrent vasovagal syncopeIRCT20180125038507N1Tehran University of Medical Sciences50
进行中（未招募）
1 期
Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid DyslexiaAttention-Deficit/Hyperactivity DisorderMedDRA version: 23.0Level: LLTClassification code 10003735Term: Attention deficit-hyperactivity disorderSystem Organ Class: 100000004873EUCTR2017-000739-15-Outside-EU/EEAEli Lilly and Company
招募中
2 期
Study of the effect of Atomoxetine on cognitive symptoms in patients with schizophreniaIRCT20101130005280N31Mashhad University of Medical Sciences42
尚未招募
3 期
Comparison the efficacy of Attentalin and Atomoxetin in ADHDIRCT20230419057960N1Hamedan University of Medical Sciences46